BRCA2 and pancreatic neoplasm: Klein et al. highlight the prevalence of BRCA2 mutations in patients with pancreatic cancer ranging from 1.4% to 16%, with the higher rates observed in individuals with a family history of pancreatic, ovarian, or breast cancer.